Literature DB >> 21075606

Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain.

Azucena Mora1, Miguel Blanco, Cecilia López, Rosalia Mamani, Jesús E Blanco, María Pilar Alonso, Fernando García-Garrote, Ghizlane Dahbi, Alexandra Herrera, Ana Fernández, Begoña Fernández, Andrés Agulla, Germán Bou, Jorge Blanco.   

Abstract

CTX-M enzymes, mainly CTX-M-14 and CTX-M-15, have emerged as the most prevalent extended-spectrum β-lactamase (ESBL) type produced by Escherichia coli in Spain, with successful dissemination of clonal group O25b:H4-B2-ST131 producing CTX-M-15 within the hospital and community settings. However, until now CTX-M-14-producing E. coli in Spain had been shown to belong to a wide variety of serotypes with no predominance of a certain clonal group. In the present study, 654 E. coli strains positive for ESBL production obtained between 2005 and 2008 from inpatients and outpatients of four hospitals in Galicia, northwest Spain, were analysed. The strains were characterised with regard to ESBL enzymes, serotype, virulence genes, phylogenetic group, multilocus sequence type, and pulsed-field gel electrophoresis of XbaI-digested DNA. As a result, the emergence of certain clonal groups of extraintestinal pathogenic E. coli producing CTX-M-14 has been detected in this geographic area, including O1:HNM-D-ST59, O15:H1-D-ST393/ST1394, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101. These five clonal groups showed a high virulence potential as they harboured more than eight virulence factors, which could explain their successful dissemination.
Copyright © 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21075606     DOI: 10.1016/j.ijantimicag.2010.09.012

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  23 in total

Review 1.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 2.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

3.  Extended-spectrum-β-lactamase-producing Escherichia coli as a cause of pediatric infections: report of a neonatal intensive care unit outbreak due to a CTX-M-14-producing strain.

Authors:  Jesús Oteo; Emilia Cercenado; Sara Fernández-Romero; David Saéz; Belén Padilla; Elena Zamora; Oscar Cuevas; Verónica Bautista; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

4.  Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.

Authors:  Amee R Manges; Hyun Min Geum; Alice Guo; Thaddeus J Edens; Chad D Fibke; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2019-06-12       Impact factor: 26.132

5.  Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality.

Authors:  Hsing-Chun Chung; Chung-Hsu Lai; Jiun-Nong Lin; Chun-Kai Huang; Shiou-Haur Liang; Wei-Fang Chen; Yi-Chun Shih; Hsi-Hsun Lin; Jiun-Ling Wang
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

6.  Molecular identification of extended-spectrum-β-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland.

Authors:  Nadine Geser; Roger Stephan; Bozena M Korczak; Lothar Beutin; Herbert Hächler
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

7.  Prevalence of Extended-Spectrum-β-Lactamase- and/or Carbapenemase-Producing Escherichia coli Isolated from Yellow-Legged Gulls from Barcelona, Spain.

Authors:  Andrea Vergara; Cristina Pitart; Tomás Montalvo; Ignasi Roca; Sara Sabaté; Juan Carlos Hurtado; Raquel Planell; Francesc Marco; Beatriz Ramírez; Víctor Peracho; Mercé de Simón; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

8.  First Report of the Globally Disseminated IncX4 Plasmid Carrying the mcr-1 Gene in a Colistin-Resistant Escherichia coli Sequence Type 101 Isolate from a Human Infection in Brazil.

Authors:  Miriam R Fernandes; John A McCulloch; Marco A Vianello; Quézia Moura; Paula J Pérez-Chaparro; Fernanda Esposito; Luciana Sartori; Milena Dropa; Maria H Matté; Débora P A Lira; Elsa M Mamizuka; Nilton Lincopan
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

9.  Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome.

Authors:  Veronika Tchesnokova; Mariya Billig; Sujay Chattopadhyay; Elena Linardopoulou; Pavel Aprikian; Pacita L Roberts; Veronika Skrivankova; Brian Johnston; Alena Gileva; Irina Igusheva; Angus Toland; Kim Riddell; Peggy Rogers; Xuan Qin; Susan Butler-Wu; Brad T Cookson; Ferric C Fang; Barbara Kahl; Lance B Price; Scott J Weissman; Ajit Limaye; Delia Scholes; James R Johnson; Evgeni V Sokurenko
Journal:  J Clin Microbiol       Date:  2013-07-10       Impact factor: 5.948

10.  Unveiling the Virulent Genotype and Unusual Biochemical Behavior of Escherichia coli ST59.

Authors:  Ana Carolina de Mello Santos; Bruna Fuga; Fernanda Esposito; Brenda Cardoso; Fernanda Fernandes Santos; Tiago Barcelos Valiatti; José Francisco Santos-Neto; Ana Cristina Gales; Nilton Lincopan; Rosa Maria Silva; Tânia Aparecida Tardelli Gomes
Journal:  Appl Environ Microbiol       Date:  2021-07-27       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.